Exodus Point Capital Management, LP Homology Medicines, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.6 - $4.17 $46,480 - $74,547	-17,877 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$3.64 - $7.78 $24,959 - $53,347	-6,857 Reduced 27.72%	17,877 $65,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $39,653 - $57,468	6,598 Added 36.38%	24,734 $195,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $109,178 - $174,831	18,136 New	18,136 $132,000
Q4 2020 Feb 16, 2021	SELL	$8.92 - $13.29 $250,946 - $373,887	-28,133 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$9.94 - $16.59 $279,642 - $466,726	28,133 New	28,133 $301,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.